Phase III Completion + NIH ACTIV-5 Completion + EUA + OWS/BARDA + Car-T w Kite/Gilead interim look (Phase III may not be required) + BLA for Lenzilumab + kickoffs for CMML (Phase II) & GVHD (Phase 2/3) & Ifab in Glioblastoma (Phase I at full enrollment already) Trial's = a very, very busy 2021 for HGEN
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.